Appriss Health is paying a reported $500m to buy healthcare collaboration platform developer PatientPing, allowing Alphabet's GV to exit.

The Access Industries-backed content engagement software producer will be valued above $11bn once the reverse merger closes.

Novo and Lundbeck are in line for exits from the mitochondrial disease therapy developer, which has raised $145m across two funding rounds.

Chegg has exited the peer-to-peer educational content platform in an acquisition of undisclosed size by UOL Edtech.

The Applied Materials and Hengtong Optic-Electric-backed photonic chipset developer will be valued at $1.2bn once the transaction closes.

The PayPal-backed provider of restaurant order management software, has added $67.5m to the $450m it raised in its initial public offering last week.

Eli Lilly has scored an exit after the inflammatory disease drug developer, which is now valued at about $1bn, went public.

SymBiosis and SIG-backed microbiome therapeutics developer Finch priced an upsized offering at the top of its range.

The BAIC and Taya Media-backed radar imaging system developer will be valued above $720m once the merger with Industrial Tech Acquisitions closes.

The Tencent-backed internet-of-things platform developer has reportedly priced its shares above their range and will list on the New York Stock Exchange.